Although there is little evidence demonstrating the involvement of mutated KRAS in MDB development (Gilbertson et al., 2006), we were able to reproduce a cancer model with features of pediatric MDB due to the specific expression of KRASG12D in ptf1a-expressing tissues (supplementary material Figs S1, S5–S9). This evidence concerns the gene ABR and cancer.